Healthcare Sector

Pharma cos brace for soft Q4; US drag persists; domestic growth cushions

Pharma sector may see a 7 per cent Y-o-Y growth in reported sales and a 1 per cent increase in Ebitda, led by steady ex-gRevlimid US sales, healthy domestic growth, and favourable forex movements

Healthcare hit across Rajasthan as private doctors go on daylong strike

Medical services in private hospitals across Rajasthan took a hit on Tuesday as doctors went on a strike following the arrest of a hospital director in Jaipur. Responding to a call by the Indian Medical Association (IMA), Rajasthan Chapter, private hospitals and nursing homes went on a strike from 8 am on April 14 to 8 am on April 15. In Jaipur, private hospitals remained shut for OPD services since morning. Patients who were already admitted, however, received treatment. The impact was visible across small and large private hospitals. Some hospitals even suspended emergency services. Authorities strengthened arrangements in government hospitals in view of the strike. In several hospitals, notices were put up informing patients about the suspension of OPD services for the day. Some patients who reached hospitals were seen making enquiries before leaving for government hospitals. "The protest is part of a symbolic strike, and doctors have indicated that further agitation may follo

Health-tech firm Practo builds out leadership bench ahead of potential IPO

Health-tech firm hires senior executives across operations, AI and strategy as it targets $1 billion GMV and prepares for a potential IPO by year-end

Nifty Healthcare below 100-WMA, down 8% from its peak; what charts say?

Amol Athawale of Kotak Securities believes that the short-term outlook for Nifty Healthcare remains uncertain and sentiment may turn negative in case the index falls below 13,500 levels.

Domestic medtech lobby seeks govt support as key input costs rise 50%

Domestic medical device makers seek government support as input costs surge up to 50 per cent amid West Asia disruptions, flagging supply chain stress and rising logistics costs

Healthcare must be affordable, Ayushman Bharat fulfils this vision: PM Modi

Prime Minister Narendra Modi on Sunday said healthcare should be accessible, available and affordable to all and that the Ayushman Bharat scheme is already fulfilling this vision for crores of families across India. In his address after launching projects worth over Rs 2,700 crore here, he said the Central government included Puducherry under the special assistance for capital investment scheme meant only for states. This move benefits the people of the Union territory by way of better infrastructure including better roads. He said: "A strong, empowered youth is the foundation for growth. We are working to support their dreams. At NIT Karaikal, the new Dr APJ Abdul Kalam engineering block and modern hostel facilities will strengthen technical education for many students." Also, he pointed out that infrastructure upgrades have been done in Pondicherry University as well. Furthermore, he said: "When I came here earlier, I had given the mantra of BEST Puducherry. BEST means Business,

Fortis Healthcare Q3 results: Profit falls 21.8%; revenue up 17.5%

Hospital chain reports ₹193.7 crore net profit in Q3 FY26 amid one-time expense; hospital and diagnostics segments post revenue growth and margin expansion

Maha Govt signs MoUs worth ₹10,880 cr for multiple Vidarbha projects

The Maharashtra government signed MoUs worth over ₹10,880 crore for solar, healthcare and manufacturing projects in Vidarbha. It will also roll out new industrial policies soon

India's single-specialty healthcare market to triple to over $12 bn by 2030

Report points to a structural shift in India's $54 billion healthcare market as focused, asset-light providers scale alongside large hospitals

Budget 2026: Biopharma to medical tourism, push for healthcare value chain

Union Budget 2026 proposes measures across biopharma manufacturing, medical education, research, affordable drugs, AYUSH and medical tourism, signalling a deeper healthcare strategy

Budget 2026: Govt to set up 5 medical tourism hubs, train 150K caregivers

Finance Minister Nirmala Sitharaman announced measures in the Union Budget 2026-27 to boost medical tourism, including support for five regional hubs in partnership with states and the private sector

Nivaan Care raises $7 million to expand pain management clinics in India

Series A round led by Sorin Investments backs the rollout of minimally invasive, single specialty centres

Australia can rein in health spending with stronger focus on prevention

Australia's spending on health and social care is growing as a share of the economy and now makes up five of the top seven fiscal pressures facing the federal budget

HDFC Sec turns bullish on Dr Lal PathLabs; upgrades to 'Buy'; raises target

Dr Lal PathLabs is focusing on innovation, including new wellness packages and high-end, super-speciality tests, with a focus on capturing prescription shares

Healthcare IPO count jumps in 2025; fundraising flat, returns soften

The surge has come alongside a decline in average issue sizes and more muted listing-day returns compared with last year

Year-ender 2025: Financials, new-age cos dominate India's IPO fundraising

Financial services accounted for the largest share of IPO issuance in 2025, reflecting strong issuance from NBFCs, asset managers, insurers and financial platforms during the year

Fortis Healthcare gains on Bengaluru expansion; JM Financial upgrades stock

JM Financial has set a target price of ₹1,093 on Fortis Healthcare stock, a potential upside of 22.7 per cent from Friday's closing price

Gujarat Kidney IPO: Fair valuations, analysts cautious; should you bid?

The three-day subscription window to bid for the Gujarat Kidney IPO will close on Wednesday, December 24, 2025

Investing in Gujarat Kidney IPO? Check 5 key risks before you decide

Gujarat Kidney IPO will be offered at a price band of ₹108 to ₹114 per share, with a lot size of 128 shares

Motilal Oswal initiates IKS, Sagility with 'Buy'; Indegene 'Neutral'

The US remains the world's most lucrative outsourcing market, with healthcare spending touching nearly $5 trillion in CY24, accounting for 17-18 per cent of GDP.